Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 21 (Search time: 0.001 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2019APOMAB antibody-drug conjugates targeting dead tumor cells are effective in vivoStaudacher, A.H.; Li, Y.; Liapis, V.; Hou, J.J.C.; Chin, D.; Dolezal, O.; Adams, T.E.; van Berkel, P.H.; Brown, M.P.
2019OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALLEvans, K.; Duan, J.X.; Pritchard, T.; Jones, C.D.; McDermott, L.; Gu, Z.; Toscan, C.E.; El-Zein, N.; Mayoh, C.; Erickson, S.W.; Guo, Y.; Meng, F.; Jung, D.; Rathi, K.S.; Roberts, K.G.; Mullighan, C.G.; Shia, C.S.; Pearce, T.; Teicher, B.A.; Smith, M.A.; et al.
2019Bcl-2 is a therapeutic target for hypodiploid b-lineage acute lymphoblastic leukemiaDiaz-Flores, E.; Comeaux, E.Q.; Kim, K.L.; Melnik, E.; Beckman, K.; Davis, K.L.; Wu, K.; Akutagawa, J.; Bridges, O.; Marino, R.; Wohlfeil, M.; Braun, B.S.; Mullighan, C.G.; Loh, M.L.
2019Disruptive variants of CSDE1 associate with autism and interfere with neuronal development and synaptic transmissionGuo, H.; Li, Y.; Shen, L.; Wang, T.; Jia, X.; Liu, L.; Xu, T.; Ou, M.; Hoekzema, K.; Wu, H.; Gillentine, M.A.; Liu, C.; Ni, H.; Peng, P.; Zhao, R.; Zhang, Y.; Phornphutkul, C.; Stegmann, A.P.A.; Prada, C.E.; Hopkin, R.J.; et al.
2019Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitisKopecki, Z.; Yang, G.; Treloar, S.; Mashtoub, S.; Howarth, G.S.; Cummins, A.G.; Cowin, A.J.
2019Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastomaNeubauer, H.A.; Tea, M.N.; Zebol, J.R.; Gliddon, B.L.; Stefanidis, C.; Moretti, P.A.B.; Pitman, M.R.; Costabile, M.; Kular, J.; Stringer, B.W.; Day, B.W.; Samuel, M.S.; Bonder, C.S.; Powell, J.A.; Pitson, S.M.
2019Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancerWatt, M.J.; Clark, A.K.; Selth, L.A.; Haynes, V.R.; Lister, N.; Rebello, R.; Porter, L.H.; Niranjan, B.; Whitby, S.T.; Lo, J.; Huang, C.; Schittenhelm, R.B.; Anderson, K.E.; Furic, L.; Wijayaratne, P.R.; Matzaris, M.; Montgomery, M.K.; Papargiris, M.; Norden, S.; Febbraio, M.; et al.
2019Heterozygous loss of function of IQSEC2/Iqsec2 leads to increased activated Arf6 and severe neurocognitive seizure phenotype in femalesJackson, M.R.; Loring, K.E.; Homan, C.C.; Thai, H.N.; Määttänen, L.; Arvio, M.; Jarvela, I.; Shaw, M.; Gardner, A.; Gecz, J.; Shoubridge, C.
2019Cancer-associated fibroblasts—heroes or villains?Gieniec, K.A.; Butler, L.M.; Worthley, D.L.; Woods, S.L.
2019Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomesJiao, Y.; Davis, J.E.; Rautela, J.; Carrington, E.M.; Ludford-Menting, M.J.; Goh, W.; Delconte, R.B.; Souza-Fonseca-Guimaraes, F.; Koldej, R.; Gray, D.; Huang, D.; Kile, B.T.; Lew, A.M.; Ritchie, D.S.; Huntington, N.D.